Overexpression of Hp95 induces G1 phase arrest in confluent HeLa cells

被引:40
作者
Wu, Y
Pan, SJ
Che, SL
He, GG
Nelman-Gonzalez, M
Weil, MM
Kuang, J
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
基金
美国国家科学基金会;
关键词
Xp95; Xenopus laevis; oocyte maturation; Hela cells; cell cycle; signal transduction;
D O I
10.1046/j.1432-0436.2001.670406.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Xp95, a protein recently identified in Xenopus laevis, is potentially involved in progesterone-induced Xenopus oocyte maturation. In this study, we cloned a human homologue of Xp95, designated Hp95, and examined the effect of its overexpression on the growth properties of human malignant HeLa cells which have lost the contact inhibition of cell proliferation. We observed that although HeLa cells did not undergo GI phase arrest at any stage after confluence, they were able to downregulate their GI phase CDK activities in response to confluence. When Hp95 was overexpressed in HeLa cells by transfection with a constitutive or an inducible expression vector containing a full-length Hp95 transgene, HeLa cells became able to undergo Gl phase arrest and form a monolayer culture after confluence. However, the GI phase CDK activities in these Hp95 overexpressing cells were not inhibited further as compared to control cells after confluence. These results indicate that the defects in HeLa cells that cause the loss of contact inhibition of cell proliferation are in components downstream of the GI phase CDKs and that overexpression of Hp95 counteracts some of these defects.
引用
收藏
页码:139 / 153
页数:15
相关论文
共 55 条
[31]   Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein [J].
Missotten, M ;
Nichols, A ;
Rieger, K ;
Sadoul, R .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (02) :124-129
[32]   COMPLEX-FORMATION OF HUMAN PAPILLOMAVIRUS-E7 PROTEINS WITH THE RETINOBLASTOMA TUMOR SUPPRESSOR GENE-PRODUCT [J].
MUNGER, K ;
WERNESS, BA ;
DYSON, N ;
PHELPS, WC ;
HARLOW, E ;
HOWLEY, PM .
EMBO JOURNAL, 1989, 8 (13) :4099-4105
[33]   Characterization of the pH signal transduction pathway gene palA of Aspergillus nidulans and identification of possible homologs [J].
NegreteUrtasun, S ;
Denison, SH ;
Arst, HN .
JOURNAL OF BACTERIOLOGY, 1997, 179 (05) :1832-1835
[34]  
Nickas ME, 1996, MOL CELL BIOL, V16, P2585
[35]  
OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612
[36]   CELLULAR TRANSFORMATION AND MORPHOLOGIC PHENOTYPE OF TRANSFORMED-CELLS [J].
PASTAN, I ;
WILLINGHAM, M .
NATURE, 1978, 274 (5672) :645-650
[37]   HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 SEQUENCES IN CARCINOMA CELL-LINES OF THE CERVIX [J].
PATER, MM ;
PATER, A .
VIROLOGY, 1985, 145 (02) :313-318
[38]   P27(KIP1), A CYCLIN-CDK INHIBITOR, LINKS TRANSFORMING GROWTH-FACTOR-BETA AND CONTACT INHIBITION TO CELL-CYCLE ARREST [J].
POLYAK, K ;
KATO, JY ;
SOLOMON, MJ ;
SHERR, CJ ;
MASSAGUE, J ;
ROBERTS, JM ;
KOFF, A .
GENES & DEVELOPMENT, 1994, 8 (01) :9-22
[39]   STRUCTURE AND TRANSCRIPTION OF HUMAN PAPILLOMAVIRUS SEQUENCES IN CERVICAL-CARCINOMA CELLS [J].
SCHWARZ, E ;
FREESE, UK ;
GISSMANN, L ;
MAYER, W ;
ROGGENBUCK, B ;
STREMLAU, A ;
HAUSEN, HZ .
NATURE, 1985, 314 (6006) :111-114
[40]   Anticancer drug targets: cell cycle and checkpoint control [J].
Shapiro, GI ;
Harper, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (12) :1645-1653